print PRINT


Astellas Pharma to invest in U.S. incubation facility

  • October 10, 2019
  • , NIKKEI Business Daily , p. 9
  • JMH Translation

Astellas Pharma has announced it will invest some 13 million dollars (roughly 1.4 billion yen) in an incubation facility in the Boston area of the U.S. The Japanese company aims to create innovation for stem cell therapy and gene therapy to fulfill unmet patient needs. (Abridged)

  • Ambassador
  • Ukraine
  • COVID-19
  • Trending Japan